Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-08

FDA Approved: LEVALBUTEROL — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for levalbuterol products from Mylan Pharmaceuticals Inc. under the ANDA program. This action confirms approval of addit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levalbuterol (Levalbuterol)
  • Levalbuterol hydrochloride (Levalbuterol hydrochloride)

Snippet

SUPPL AP for LEVALBUTEROL (LEVALBUTEROL)